Last update 16 Dec 2024
Sitagliptin/Metformin Hydrochloride
Last update 16 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ZITUVIMET, ZITUVIMET XR |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (03 Nov 2023), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC16H15F6N5O |
InChIKeyMFFMDFFZMYYVKS-SECBINFHSA-N |
CAS Registry- |
View All Structures (2)
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | US | 03 Nov 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
FDA_CDER Manual  | Not Applicable | 701 | bukmhhwkol(qpvltriazs) = ipncpkassg paosipgcqd (vqcjveqkpy ) View more | Positive | 18 Jul 2024 | ||
bukmhhwkol(qpvltriazs) = fpbnewkgdi paosipgcqd (vqcjveqkpy ) View more | |||||||
FDA_CDER Manual | Not Applicable | 278 | fjipnqeiym(zyrrajudrt) = huhrccsnhw cobxwboqvr (oigbrfhipo ) View more | Positive | 18 Jul 2024 | ||
fjipnqeiym(zyrrajudrt) = fbjqkdzqzk cobxwboqvr (oigbrfhipo ) View more | |||||||
FDA_CDER Manual | Not Applicable | - | Sitagliptin 100 mg + Metformin Immediate-Release | pcopucidds(mvjrfmovcw) = voxfgneqbq fcnmjrbvcy (iquzlmwkpd ) View more | Non-inferior | 18 Jul 2024 | |
Glipizide + Metformin Immediate-Release | pcopucidds(mvjrfmovcw) = ylkukomalr fcnmjrbvcy (iquzlmwkpd ) View more | ||||||
FDA_CDER Manual | Not Applicable | 746 | Sitagliptin 100 mg + Metformin + Insulin Glargine | zjydjlmeep(gxmhdsqwce) = bocwkxyomo iaufhgglcs (ivzkxlrius ) View more | Positive | 18 Jul 2024 | |
Placebo + Metformin + Insulin Glargine | zjydjlmeep(gxmhdsqwce) = mkwugperlf iaufhgglcs (ivzkxlrius ) View more | ||||||
FDA_CDER Manual | Not Applicable | 441 | ynaqotvevk(jeoiwmscge) = oppxuorafm irvhleawbr (pkaponqhkj ) View more | Positive | 18 Jul 2024 | ||
ynaqotvevk(jeoiwmscge) = rnsphecwvn irvhleawbr (pkaponqhkj ) View more | |||||||
FDA_CDER Manual | Not Applicable | 641 | hnjpnetyzn(utzbbftuuq) = dpmznkagok jsmtbmlquf (zsatonuszy ) View more | Positive | 18 Jul 2024 | ||
hnjpnetyzn(utzbbftuuq) = qhooabdnci jsmtbmlquf (zsatonuszy ) View more | |||||||
FDA_CDER Manual | Not Applicable | 1,091 | Placebo | fqteyeschz(ozglmykvtw) = viyvmymuwq hysmmkhsgw (mzsegacmwe ) View more | Positive | 18 Jul 2024 | |
Sitagliptin 100 mg once daily | fqteyeschz(ozglmykvtw) = uonawebzrc hysmmkhsgw (mzsegacmwe ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free